Drip infusion cholangiography using iotroxamide. Double blind comparison with ioglycamide

Area of Science:

• Radiology
• Medical Imaging
• Pharmacology

Background:

• Intravenous cholangiography is crucial for diagnosing biliary tract diseases.
• Ioglycamide and iotroxamide are iodinated contrast media used for this procedure.
• Comparative efficacy and safety data are essential for clinical decision-making.

Purpose of the Study:

• To compare the efficacy and tolerance of ioglycamide and iotroxamide.
• To evaluate contrast enhancement of the bile duct.
• To assess the incidence of adverse events associated with each contrast agent.

Main Methods:

• A double-blind clinical trial involving 200 unselected patients.
• Slow infusion of ioglycamide and iotroxamide at 2.6 mumoles/kg/min for one hour.
• Independent radiological assessment of bile duct opacification and recording of side effects.

Main Results:

• Iotroxamide provided significantly better bile duct visualization than ioglycamide in patients with serum bilirubin < 34 mumoles/litre (P < 0.001).
• Toxic side effects occurred in 8% of patients receiving ioglycamide.
• Only 3% of patients receiving iotroxamide experienced toxic side effects.

Conclusions:

• Iotroxamide is a more effective and better-tolerated contrast agent for intravenous cholangiography than ioglycamide.
• The findings support the use of iotroxamide for improved diagnostic accuracy and patient safety.
• Further research may explore optimal dosing and patient selection for iotroxamide.